Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)NewsBilanz/GuVDividende/HVZertifikateDepot/Watchlist
Times + SalesChart-AnalyseAnalysenSchätzungenTermineOptionsscheinemyHome
BörsenplätzeChartvergleichKurszieleVergleichProfilKnock-OutsSenden
OrderbuchRealtime StuttgartFundamentalanalyseRatingInsidertradesFondsInvestmentreport
HistorischRealtime PushmyNews im ForumAnleihen
Kaufen
Verkaufen

Gilead Sciences News

  • Sprache:
  • Alle
  • DE
  • EN
  • Sortieren:
  • Datum
  • meistgelesen
27.02.15
Gilead Sciences: 'HIV Succession Plan Coming Into Focus' (EN, The Wall Street Journal Deutschland)
27.02.15
Gilead Sciences: ‘HIV Succession Plan Coming Into Focus’ (EN, Barrons)
27.02.15
Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences (Globe Newswire)
27.02.15
Pharmalot, Pharmalittle: As the Weekend Nears, We're Reading About Gilead, Novartis and Lots More!! (EN, The Wall Street Journal Deutschland)
26.02.15
Biotech Head-to-Head: Gilead vs. Celgene (EN, MotleyFool)
26.02.15
Gilead Sciences: Despite Dividend, Still Room For Growth (EN, The Wall Street Journal Deutschland)
26.02.15
Gilead Sciences: Despite Dividend, Still Room For Growth (EN, Barrons)
26.02.15
Pharmalot, Pharmalittle: We're Reading About Pharmacyclics, Gilead and Much More!! (EN, The Wall Street Journal Deutschland)
25.02.15
Gilead & AbbVie: It Doesn't Matter Which Drug is Better, Just Who Will Pay (EN, The Wall Street Journal Deutschland)
25.02.15
Gilead & AbbVie: It Doesn’t Matter Which Drug is Better, Just Who Will Pay (EN, Barrons)
23.02.15
Gilead Sciences: What if AbbVie's Doing Better Than We Think? (EN, The Wall Street Journal Deutschland)
23.02.15
Gilead Sciences: What if AbbVie’s Doing Better Than We Think? (EN, Barrons)
21.02.15
Overheard: Gilead Needs More Tracks (EN, The Wall Street Journal Deutschland)
20.02.15
Gilead Sciences: How Strong are Hepatitis-C Sales? (EN, The Wall Street Journal Deutschland)
20.02.15
Gilead Sciences: How Strong are Hepatitis-C Sales? (EN, Barrons)
19.02.15
11.7 Billion Reasons Gilead Sciences, Inc. Should Keep Winning (EN, MotleyFool)
18.02.15
Is Gilead Sciences Inc. Stock Cheap Now? (EN, MotleyFool)
17.02.15
Why Gilead Sciences Doesn’t Seem Too Worried About AbbVie’s Hep-C Treatment (EN, Barrons)
17.02.15
Why Gilead Sciences Doesn't Seem Too Worried About AbbVie's Hep-C Treatment (EN, The Wall Street Journal Deutschland)
16.02.15
Could This Be The Biggest Advance in Hepatitis C since Gilead Sciences' Sovaldi? (EN, MotleyFool)
15.02.15
Was Gilead Sciences Inc.'s Dividend a Good Idea? (EN, MotleyFool)
14.02.15
1 Number Shows Why Gilead Sciences, Inc. Shareholders Should Be Thrilled Right Now (EN, MotleyFool)
13.02.15
Gilead Sciences: Hepatitis-C Tracking at High End of Guidance, RBC Says (EN, The Wall Street Journal Deutschland)
13.02.15
Pharmalot, Pharmalittle: As the Weekend Nears, We're Reading About Gilead, Salix, Hospira and Much More!! (EN, The Wall Street Journal Deutschland)
12.02.15
Pharma-Streit: Gilead muss Krankenkassen Beträge erstatten (Handelsblatt)
12.02.15
The Hepatitis C Scorecard: Gilead is Trouncing AbbVie, but at a Price (EN, The Wall Street Journal Deutschland)
12.02.15
Forget Gilead Sciences: Here Are 3 Better Biotech Stocks (EN, MotleyFool)
11.02.15
Gilead Sciences: 'Significant Reassurance to Skittish Investors' (EN, The Wall Street Journal Deutschland)
11.02.15
Gilead Sciences: ‘Significant Reassurance to Skittish Investors’ (EN, Barrons)
10.02.15
Gilead Faces Sovaldi Patent Challenge in Europe by a Non-Profit Group (EN, The Wall Street Journal Deutschland)
09.02.15
Canada Will Have a Gilead of the North Within 10 Years (Proactiveinvestors)
09.02.15
Gilead Walloped by Lower Pricing View on Hepatitis C (EN, The Wall Street Journal Deutschland)
07.02.15
What's Bad For Gilead Sciences and Merck Is a Good Sign for Patients (EN, MotleyFool)
07.02.15
Can You Guess the Stock Putting Gilead Sciences to Shame? (Hint: It's Not AbbVie) (EN, MotleyFool)
06.02.15
Gilead Sciences (GILD) Stock Lower Today After Credit Suisse Downgrade (EN, TheStreet.com)
06.02.15
Gilead Sciences, AbbVie and the End of the Hepatitis-C Trade (EN, Barrons)
06.02.15
Morning Movers: Frontier Communications Gains on Verizon Landline Purchase; Gilead Drops on Downgrade (EN, The Wall Street Journal Deutschland)
06.02.15
Morning Movers: Frontier Communications Gains on Verizon Landline Purchase; Gilead Drops on Downgrade (EN, Barrons)
06.02.15
Analysts' Actions: Best Buy, Expedia, Gilead, GrubHub and More (EN, TheStreet.com)
05.02.15
No, the Gilead-AbbVie Price War Won't Spill Over Into Other Drugs (EN, The Wall Street Journal Deutschland)
Seite: 123456789...16

Gilead Sciences News

Gilead Sciences News: auf dieser Seite finden Sie alle Gilead Sciences News und Nachrichten zur Gilead Sciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Gilead Sciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Gilead Sciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.